ロード中...
AB030. Evolution of phosphodiesterase type 5 inhibitors
After launching of sildenafil citrate, the last invention of 20(th) century, in 1998, oral phosphodiesterase type 5 (PDE5) inhibitor has been established as first line treatment of erectile dysfunction and shift new paradigm of diagnosis and treatment of erectile dysfunction. The big success of sild...
保存先:
| 出版年: | Transl Androl Urol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4842502/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.s030 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|